Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
NIO752, Isotone Kochsalz-Lösung 0,9 % Braun Infusionslösung
Novartis Pharmaceuticals
Participants with Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)
1 trial -
NIRMATRELVIR, NIRMATRELVIR, Ritonavir, nirmatrelvir / ritonavir
Pfizer Australia Pty Ltd
SARS-CoV-2 Infection
1 trial -
NIVOLUMAB, Bemarituzumab, OXALIPLATIN, FOLINIC ACID, Placebo for AMG 552, CAPECITABINE , FLUOROURACIL
Amgen
Gastric and Gastroesophageal Junction Cancer With FGFR2b Overexpression
1 trial -
NKTR-118
AstraZeneca
Opioid-Induced Constipation
1 trial -
NORADRENALINA TARTRATO MONICO 2 mg/ml Concentrato per soluzione per infusione
Lacuna Pharma Pty Ltd
criticall illness
1 trial -
NP101 Sumatriptan Iontophoretic Transdermal Patch
Teva Pharma GmbH
Migraine Disorders
2 trials -
NPC-11 for intravenous or oral administration.
Belpharma s.a.
Apnea of Prematurity
1 trial -
NTLA-2001
Regeneron UK Limited
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
1 trial -
NaCl 0,9 % B. Braun, solution injectable, Depo-Medrone 40 mg/ml Suspension for Injection.
Disc Medicine
Cluster headache
1 trial -
NaCl 0.9%, TRANEXAMIC ACID, TERLIPRESSIN
Pari Pharma GmbH
Hemoptysis, whatever the cause, with the exception of cystic fibrosis
1 trial -
Nabilone
BRIGHT MINDS BIOSCIENCES INC.
Cannabis Dependence
1 trial -
Nabilone
BRIGHT MINDS BIOSCIENCES INC.
Alzheimer Disease
1 trial -
Nacubactam, Imipenem/Cilastatin Kabi 500 mg/500 mg Pulver zur Herstellung einer Infusionslösung, Cefepim PANPHARMA 2 g Pulver zur Herstellung einer Injektions- bzw. Infusionslösung, AZACTAM 1 g, poudre et solution pour usage parentéral
Lacuna Pharma Pty Ltd
Complicated urinary tract infection (cUTI) and acute uncomplicated pyelonephritis (AP)
1 trial -
Naltrexone
BRIGHT MINDS BIOSCIENCES INC.
Alcoholism
1 trial -
Namodenoson
Can-Fite BioPharma
Hepatocellular Carcinoma
1 trial -
Namuscla 167 mg hard capsules, Mexiletine granules for prolonged-release oral suspension 167 mg, Mexiletine granules for prolonged-release oral suspension 500 mg, Mexiletine granules for prolonged-release oral suspension 333 mg
Lupin Europe GmbH
Non-Dystrophic Myotonias (NDM)
1 trial -
Nano-crystalline Megestrol Acetate Oral Suspension
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
1 trial -
Nanocovax
Biotech Pharmaceutical Co.,
SARS-CoV-2 Infection
1 trial -
Napabucasin, Bendatax 6 mg/ ml, Bendacitabin 38 mg/ml Pulver zur Herstellung einer Infusionslösung
The George Institute
Histologically or cytologically confirmed advanced pancreatic adenocarcinoma that is metastatic.
1 trial -
Natriumklorid Braun 9 mg/ml spädningsvätska för parenteral användning, COLECALCIFEROL , GRAZAX 75 000 SQ-T frystorkad sublingual tablett, Alutard SQ Timotej, 10 000 SQ-E/ml, injektionsvätska, suspension
The George Institute
Allergisk Rinit
1 trial -
Neofordex 40 mg tablets, IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM., PREDNISONE
Pari Pharma GmbH
Adult patients with immune thrombocytopenia (ITP) with mild to severe bleeding manifestations
1 trial -
Neofordex 40 mg tablets, Imnovid 4 mg hard capsules, Imnovid 1 mg hard capsules, DARZALEX 1800 mg solution for injection, Imnovid 2 mg hard capsules, Privigen 100 mg/ml solution for infusion, ELRANATAMAB, Imnovid 3 mg hard capsules
Pfizer Australia Pty Ltd
MULTIPLE MYELOMA
1 trial -
Neuraceq 300 MBq/mL solution for injection
Fondazione Telethon ETS
cardiac amyloidosis
1 trial -
Neutral salts of dextroamphetamine sulfate, USP, amphetamine sulphate, USP, d-amphetamine saccharate, d, l-amphetamine aspartate monohydrate.
Takeda
Attention Deficit Disorder With Hyperactivity
4 trials
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources